# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-059533
Filing Date
2025-04-29
Accepted
2025-04-29 06:05:38
Documents
19
Period of Report
2025-06-11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | krro-20250428.htm iXBRL | DEF 14A | 1074695
2 | GRAPHIC | img84946324_0.jpg | GRAPHIC | 59164
3 | GRAPHIC | img84946324_1.jpg | GRAPHIC | 59164
4 | GRAPHIC | img84946324_2.jpg | GRAPHIC | 367770
5 | GRAPHIC | img84946324_3.jpg | GRAPHIC | 370044
6 | GRAPHIC | img84946324_4.jpg | GRAPHIC | 608700
7 | GRAPHIC | img84946324_5.jpg | GRAPHIC | 412380
| Complete submission text file | 0000950170-25-059533.txt |  | 6407412

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | krro-20250428.xsd | EX-101.SCH | 13704
21 | EXTRACTED XBRL INSTANCE DOCUMENT | krro-20250428_htm.xml | XML | 348411

Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39062 | Film No.: 25882476
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)